Expertise in
2
conditions

Sally E. Hay-Baron

Royal North Shore Hospital
St Leonards, NSW, AU 
Expertise in
2
conditions
Royal North Shore Hospital
St Leonards, NSW, AU 

Overview

Sally Hay-Baron practices practicing medicine in St Leonards, Australia.

Ms. Hay-Baron is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Breast Cancer, Ovarian Cancer, Osmotic Demyelination Syndrome, and Mastectomy.

She is actively involved in clinical research, co-authoring 37 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Royal North Shore Hospital
St Leonards, NSW, Australia
Other Locations
Syndey, NSW, Australia
North Shore Health Hub, St Leonard, North Shore, NSW, Australia
Newcastle, NSW, Australia
St George Hospital
Kogarah, NSW, Australia
Royal North Shore Hospital
Sydney, NSW, Australia
Melbourne, VIC, Australia
Malvern, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

SORAYA: A Phase 3, Single Arm Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
SORAYA: A Phase 3, Single Arm Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
Enrollment Status: Completed
Publish Date: August 07, 2024
Intervention Type: Drug
Study Drug: Mirvetuximab Soravtansine
Study Phase: Phase 3

37 Total Publications

Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775.
Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775.
Journal: Journal for immunotherapy of cancer
Published: January 20, 2026

Frequently Asked Questions about Sally E. Hay-Baron

Is Sally E. Hay-Baron a top-rated expert for Endometrial Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Sally E. Hay-Baron is classified as an Advanced expert for Endometrial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sally E. Hay-Baron participate in research or clinical trials?

Yes. Sally E. Hay-Baron has published 37 articles and abstracts on conditions like Endometrial Cancer. You can view a list of Sally E. Hay-Baron's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hay-Baron's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile